← Evidence map

ArticleCancers2023

Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL

Markus Stana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37046627